
TY  - JOUR
TI  - Rural Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_16.x
DO  - doi:10.1111/j.1445-2197.2010.05298_16.x
SP  - A76
EP  - A77
PY  - 2010
ER  - 

TY  - JOUR
TI  - ANZSCMFS (Craniomaxillofacial Surgery) Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_2.x
DO  - doi:10.1111/j.1445-2197.2010.05298_2.x
SP  - A5
EP  - A5
PY  - 2010
ER  - 

TY  - JOUR
TI  - Paediatric Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_13.x
DO  - doi:10.1111/j.1445-2197.2010.05298_13.x
SP  - A53
EP  - A55
PY  - 2010
ER  - 

TY  - JOUR
TI  - Pain Medicine Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_14.x
DO  - doi:10.1111/j.1445-2197.2010.05298_14.x
SP  - A56
EP  - A57
PY  - 2010
ER  - 

TY  - JOUR
TI  - Surgical Oncology Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_20.x
DO  - doi:10.1111/j.1445-2197.2010.05298_20.x
SP  - A87
EP  - A89
PY  - 2010
ER  - 

TY  - JOUR
TI  - Endocrine Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_6.x
DO  - doi:10.1111/j.1445-2197.2010.05298_6.x
SP  - A25
EP  - A29
PY  - 2010
ER  - 

TY  - JOUR
TI  - Hapatopancreaticobiliary and Upper GI Surgery Program Abstracts
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_9.x
DO  - doi:10.1111/j.1445-2197.2010.05298_9.x
SP  - A42
EP  - A48
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2018 International Conference on Biotechnology and Bioengineering (ICBB2018) 24–26 October 2018, Budapest, Hungary
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 124
IS  - S1
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.13165
DO  - doi:10.1111/bcpt.13165
SP  - 3
EP  - 43
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 58
IS  - S5
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13944
DO  - doi:10.1111/epi.13944
SP  - S5
EP  - S199
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 29
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12766_2
DO  - doi:10.1111/jgh.12766_2
SP  - 51
EP  - 313
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Abstracts of the ISPD 19th International Conference on Prenatal Diagnosis and Therapy, Washington, DC, USA, 12–15 July 2015
JO  - Prenatal Diagnosis
JA  - Prenat Diagn
VL  - 35
IS  - S1
SN  - 0197-3851
UR  - https://doi.org/10.1002/pd.4617
DO  - doi:10.1002/pd.4617
SP  - 27
EP  - 109
PY  - 2015
ER  - 

TY  - JOUR
TI  - XXVII International Congress of the International Academy of Pathology October 12-17, 2008, Athens, Greece POSTER PRESENTATIONS
JO  - Histopathology
VL  - 53
IS  - s1
SN  - 0309-0167
UR  - https://doi.org/10.1111/j.1365-2559.2008.03116.x
DO  - doi:10.1111/j.1365-2559.2008.03116.x
SP  - 1
EP  - 432
PY  - 2008
ER  - 

TY  - JOUR
TI  - Medicolegal Section Program Abstract
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_11.x
DO  - doi:10.1111/j.1445-2197.2010.05298_11.x
SP  - A50
EP  - A50
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts—Symposia
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 40
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.13085
DO  - doi:10.1111/acer.13085
SP  - 248A
EP  - 315A
PY  - 2016
ER  - 

TY  - JOUR
TI  - Posters
JO  - The FEBS Journal
JA  - FEBS J
VL  - 284
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.14174
DO  - doi:10.1111/febs.14174
SP  - 102
EP  - 403
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13961
DO  - doi:10.1111/all.13961
SP  - 376
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - 37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 19
IS  - 2
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2009.01051.x
DO  - doi:10.1111/j.1600-0625.2009.01051.x
SP  - 166
EP  - 232
PY  - 2010
ER  - 

TY  - JOUR
AU  - Loera-Valencia, R.
AU  - Cedazo-Minguez, A.
AU  - Kenigsberg, P.A.
AU  - Page, G.
AU  - Duarte, A.I.
AU  - Giusti, P.
AU  - Zusso, M.
AU  - Robert, P.
AU  - Frisoni, G. B.
AU  - Cattaneo, A.
AU  - Zille, M.
AU  - Boltze, J.
AU  - Cartier, N.
AU  - Buee, L.
AU  - Johansson, G.
AU  - Winblad, B.
TI  - Current and emerging avenues for Alzheimer's disease drug targets
JO  - Journal of Internal Medicine
JA  - J Intern Med
VL  - 286
IS  - 4
SN  - 0954-6820
UR  - https://doi.org/10.1111/joim.12959
DO  - doi:10.1111/joim.12959
SP  - 398
EP  - 437
KW  - AD gene therapy
KW  - AD molecular targets
KW  - AD therapeutics
KW  - alzheimer´s disease
KW  - amyloid beta therapies
KW  - Tau therapies
PY  - 2019
AB  - Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its progression. The most important feature of the disease is neuronal death and loss of cognitive functions, caused probably from several pathological processes in the brain. The main neuropathological features of AD are widely described as amyloid beta (A?) plaques and neurofibrillary tangles of the aggregated protein tau, which contribute to the disease. Nevertheless, AD brains suffer from a variety of alterations in function, such as energy metabolism, inflammation and synaptic activity. The latest decades have seen an explosion of genes and molecules that can be employed as targets aiming to improve brain physiology, which can result in preventive strategies for AD. Moreover, therapeutics using these targets can help AD brains to sustain function during the development of AD pathology. Here, we review broadly recent information for potential targets that can modify AD through diverse pharmacological and nonpharmacological approaches including gene therapy. We propose that AD could be tackled not only using combination therapies including A? and tau, but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, epigenetics, neurovascular junction and blood?brain barrier targets that have been studied recently. We also make a case for the role of gut microbiota in AD. Our hope is to promote the continuing research of diverse targets affecting AD and promote diverse targeting as a near-future strategy.
ER  - 

TY  - JOUR
TI  - British Society for Matrix Biology – Spring 2011 Meeting Report
JO  - International Journal of Experimental Pathology
VL  - 92
IS  - 6
SN  - 0959-9673
UR  - https://doi.org/10.1111/j.1365-2613.2011.00780.x
DO  - doi:10.1111/j.1365-2613.2011.00780.x
SP  - A1
EP  - A38
PY  - 2011
ER  - 
